INTERVIEW: ‘Worst Behind’ Troubled Indian Clinical Research Sector
This article was originally published in PharmAsia News
Executive Summary
India’s beleaguered clinical trials industry is getting back on track, the president of the Indian Society for Clinical Research has told PharmAsia News, after a string of faulty studies put the sector under a cloud. But it is seen taking until 2016 for the improved trend to become evident.